Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients

D. C. Brennan, K. A. Garlock, B. J. Lippmann, R. S. Buller, M. Gaudreault-Keener, U. A. Lowell, S. B. Miller, S. Shenoy, T. K. Howard, G. A. Storch

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)809-811
Number of pages3
JournalTransplantation proceedings
Volume29
Issue number1-2
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Brennan, D. C., Garlock, K. A., Lippmann, B. J., Buller, R. S., Gaudreault-Keener, M., Lowell, U. A., Miller, S. B., Shenoy, S., Howard, T. K., & Storch, G. A. (1997). Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients. Transplantation proceedings, 29(1-2), 809-811. https://doi.org/10.1016/S0041-1345(96)00143-1